Aegerion Pharmaceuticals Announces Presentation at the Bank of America Merrill
Lynch 2013 Healthcare Conference
CAMBRIDGE, Mass., May 3, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals,
Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the
development and commercialization of novel therapeutics to treat debilitating
and often fatal rare diseases, announced today that the company will
participate in the Bank of America Merrill Lynch 2013 Healthcare Conference.
Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present on
Wednesday, May 15, 2013 at 5:00 p.m. PT.
The presentation will be webcast live and may be accessed for up to 30 days
following the conference by visiting the "Investors" section of Aegerion's
About Aegerion Pharmaceuticals
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the
development and commercialization of innovative, life-altering therapies for
patients with debilitating, often fatal, rare diseases. For more information
about the company, please visit www.aegerion.com.
CONTACT: Aegerion Pharmaceuticals, Inc.
Manager, Investor Relations
Aegerion Pharmaceuticals, Inc. Logo
Press spacebar to pause and continue. Press esc to stop.